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Abstract.  Microvascular endothelial cells (MEC) use 
a set of surface receptors to adhere not only to the 
vascular basement membrane but, during angiogenic 
stimulation, to the interstitium. We examined how cul- 
tured human MEC interact with laminin-rich basement 
membranes. By using a panel of monoclonal antibod- 
ies, we found that MEC cells express a number of 
integrin-related receptor complexes, including cq/3t, 
¢x~, c~3/3,, ots/3~, ¢xd3~, and ¢x,/33. Attachment to lami- 
nin, a major adhesive protein in basement membranes, 
was studied in detail. Blocking monoclonal antibodies 
specific to different integrin receptor complexes 
showed that the otd3~ complex was important for MEC 
adhesion to laminin. In addition, blocking antibody 
also implicated the vitronectin receptor (o~/33) in lami- 
nin adhesion. We used ligand affinity chromatography 
of detergent-solubilized receptor complexes to further 
define receptor specificity. On laminin-Sepharose 
columns, we identified several integrin receptor com- 
plexes whose affinity for the ligand was dependent on 
the type of divalent cation present.  Several/3~  com- 
plexes, including Otl/31, O~2/31, and otd3t bound strongly 
to laminin. In agreement with the antibody blocking 
experiments, c~d33 was found to bind well to laminin. 
However, unlike binding to its other ligands (e.g., 
vitronectin, fibrinogen, von Willebrand factor), Otv/33 
interaction with larninin did not appear to be Arg-Gly- 
Asp (RGD) sensitive. Finally, immunofluorescent 
staining demonstrated both/3~  and/33 complexes in 
vinculin-positive focal adhesion plaques on the basal 
surface of MEC adhering to laminin-coated substrates. 
The results indicate that both these subfamilies of inte- 
grin heterodimers are involved in promoting MEC adhe- 
sion to laminin and the vascular basement membrane. 
T 
HE formation of  new blood vessels is essential for a va- 
riety of normal and pathological processes,  including 
growth and development, wound healing,  and initial 
growth and subsequent metastasis of malignant tumors (re- 
viewed in Folkman and Klagsbrun, 1987). Although the gen- 
eral process of angiogenesis has been described, the operat- 
ing mechanisms involved in the component events of this 
process have yet to be clearly identified. The endothelial cell 
is normally adherent to a complex basement membrane ex- 
tracellular matrix (ECM)  I (consisting of type IV collagen, 
laminin, entaetin [nidogen],  heparan sulfate proteoglycan, 
and fibronectin).  During neovaseularization,  the first event 
is  the formation of endothelial sprouts  that penetrate the 
basement membrane, then attach to and migrate through a 
meshwork of biochemically  different interstitial ECM (com- 
posed primarily of collagen types I and HI, elastin and fibro- 
nectin) toward a gradient of angiogenic factors. 
These diverse interactions  with the extracellular matrix 
must be mediated by specific surface adhesion receptors. Re- 
cent advances using various cell lines have identified the inte- 
grin superfamily of adhesion receptors as essential  mem- 
brane glycoproteins  in certain types of both cell-cell and 
1.  Abbreviations  used in  this paper:  ECM, extracellular  matrix;  MEC, 
microvascular endothelial cell. 
cell-matrix adhesions (reviewed in Buck and Horwitz, 1987; 
Ginsberg  et  al.,  1988; Hynes,  1990; Ruoslahti,  1988; 
Springer et al.,  1987; Hemler, 1990). The integrins can be 
classified according to one of at least five/3 subunits, which 
are combined with one of several o~ subunits. Integrins that 
interact with the ECM include mainly the/51 and/33 class of 
complexes.  Many  of  the  /3j  complexes  were  initially 
identified as the very late activation antigen  heterodimers 
(Hemler,  1990). 
Endothelial  cells  from both large and small vessels use 
integrin heterodimers to adhere to their extracellular ma- 
trices (Albelda et al.,  1989; Basson et al.,  1990; Charo et 
al.,  1987; Cheng and Kramer, 1989; Cheresh, 1987; Lan- 
guino et al., 1989). In our previous study (Cheng and Kra- 
mer, 1989), we reported that cultured human microvascular 
endothelial cells (MEC) express a variety of the/3~ integrin 
complexes as well as a l/b/IRa-like/3~ receptor. Since the/3~ 
.and/33 families are a group of receptors that interact  with 
many of the various ligands present in basement membranes 
and in the interstitial matrix, they may represent the major 
group of receptors that mediates endothelial cell interactions 
with the ECM (e.g., adhesion, migration, and invasion). 
Laminin is a major glycoprotein of  the basement membrane 
(Timpl,  1989). Early studies with the avian system showed 
that a set of integrin complexes reactive with a specific mono- 
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dent adhesion of cells to larmnm as well as fibronecUn and 
collagen (Buck and Horw~tz, 1987) Smce then, several other 
lamlmn-blndlng mtegnns have been identified (Wayner and 
Carter, 1987, Gelhsen et al, 1988, Ignatms and Re~chardt, 
1988, Sonnenberg et al, 1988al  Langumo et al, 1989) and 
mclude ct~3~, ot2/$~, ot~/~t, and otd~  More recently, a  new 
lammln-bmdmg 31  complex contmmng a  novel a  subunlt 
(tentaUvely o~7) has been ~dentafied on human and mouse 
melanoma cells (Kramer et al,  1989) 
In the present study we sought to define how md~vldual 
mtegnn heterodlmers functaon m  MEC adhesion to base- 
ment membranes and, m parttcular, how these receptors in- 
teract wtth larmmn  The results indicate that the wtronectxn 
receptor (ct,B3) as well as several members of the 3~ farmly 
appear to be ~mportant in promoting MEC adhesion to laml- 
nln and basement membranes 
Materials and Methods 
Cell Culture 
Mlcrovascular  endothehal  cells  were isolated  from the dernus of  human 
newborn foreslon  (Cheug  and  Kramer, 1989) The MEC  were  plated  onto 
gelatin-coated  tissue  culture  dlshes  and cultured  m Iscove's  modified  Dul- 
becco's  medmm (IDME) supplemented  wlth  9% heat-treated  newborn calf 
serum (Irvme Sclenafic,  Santa  Ana, CA), I% heat-treated  human serum 
(Sigma Chenucal Co, St Louis,  MO), and other  growth factors  as de- 
scribed  (Cheng and Kramer, 1989) For  cell-surface  labeling,  MEC  were 
radioactively  Ioclmated  wlth  lactoperoxldase  as  In  previous  studies  (Chang 
and Kramer, 1989) The cells  were solubdlzed  m detergent  and  processed 
for affimty  chromatography and immunoprecxpltauon 
Antibodies 
Prunary  anubodles  used Included mouse monoclonal anU-VLA-1 (Ts2/7, 
provided by Dr Maran Hemler, Dana Farber Cancer Institute, Boston, MA, 
Hemler et al, 1985), mouse monoclonal anu-VLA-2 (either 12FI, provided 
by Dr  Virgil Woods, Umversay of Callforma,  San Diego, Plschel et al, 
1986, or P1B5, provided by Dr Wllham Carter, Umverslty of Washington, 
Seattle, Wayner and Carter,  1987), mouse monoclonal antl-VLA-3 (either 
J143, provided by Dr L  Old, Sloane-Kettenug Insutute, New York, Fradet 
et al, 1984, or P1H5, provided by Dr. William Carter, Wayner and Carter, 
1987)1 rat monoclonal anu-VLA-5 and anU-/31 (BIE5 and AIIB2, provided 
by  Dr Caroline  Darnsky,  Umverstty of  Callforma,  San  Franclsco,  Damsky 
et  al, 1989),  rat  monoclonal anti-VLA-6  (GoH3) and  rabblt  anu-human  c¢6 
sub/ain't'  ('both  pfovlded  by Dr A  Sonnenberg, Netherlands  Cancer Insu- 
tute,  Sonnenbcrg et  al, 1988a,b),  mouse monoclonal antl-human mtegnn 
/~l  subumt (LM534), mouse monoclonal anu-human av subumt  (LM142), 
and c~v/33  Vltronectm  receptor  complex (LM609), provlded  by Dr David 
Cheresh,  Research  Institute  of  Scnpps  Chine,  Palo  Alto,  CA, Cheresh and 
Splro,  1987),  and  rabbit  polyclonal  anUboches  agmnst the  human placental 
fibronectm  receptor  that  react  wlth the  131 subumt (provlded  by Dr Erklo 
Ruoslahtl,  La  Jolla  Cancer  Foundatlon,  CA, Pytela  et  al, 1985),  rabblt  an- 
tlbody  to  human/33 (GPIIb/IIIa)  (provlded  by Dr Davld Phdhps, Umver- 
slty  of  Cahforma, San Franclsco,  Charo et  al, 1987) Rabblt  polyclonal 
antlbody  to  vmculm was  from  Chenucon Inter,  Inc (El  Segundo, CA), and 
mouse  monoclonal anubody  to  wnculm was  from  ICN Internauonal  (Costa 
Mesa, CA)  Protem A-Sepharose, goat  anU-mouse IgG-Scpharose, and 
goat  anti-rat  IgG-Sepharose were from Sigma Chenucal Co 
Adhesion Assay 
MEC adhesion to protein-coated polystyrene 96-well flat bottom nucrotlter 
plates was performed as previously described (Kramer et al,  1989)  Pre- 
confluent MEC were removed from ussue culture dishes by mcubauon for 
10-15 nun with 2 mM EDTA, 005% BSA m PBS  Then they were washed 
twice with IDME and resuspended m cold IDME with 0 1% BSA at a den- 
slty of 1-2  x  10  ~ cells/ml  The cells were allowed fo attach for 15 nun at 
37°C  m  a  humidified  8%  CO~  atmosphere  Adherent  cells'were then 
quantified by a colorunetnc assay for hexosanumdase, a tysosoma~  enzyme 
(Landegren,  1984) and the data was expressed as the mean of tr~phcate 
wells +  SD In some experiments, we exanuned whether minbmug protein 
synthesis would affect cell adhesion, MEC were pretreated with cycloheya- 
nude (10 #g/ml) for 3 h before their removal from the ¢hshes  For testing 
of lninbltory ant~boches  or pept~des, cells and reagents were incubated at 
4°C for 30 nun before the assay was tmUated by warnung to 37°C 
Flbronectm was purdied from out.ted human plasma by galatm-Seph- 
arose affimty chromatography (Ruoslahu et al,  1982) Both larmmn and 
type IV collagen were isolated from Engelbreth-Holm-Swarm tumors using 
the protocol of T'unpl et al  (1987) Type I collagen (>9~7%) from bovine 
skin was purchased from Collagen Corporauon (Palo Alto, CA)  The purity 
of matrix proteins was veniied by using an enzyme-hnked lmmunosorbent 
assay and unmunoblo~ng as previously described (Kramer et al,  1986) 
In the case of larmmn, neghglble amounts of contanunaung  proteins (vl- 
tronectm,  fibronecUn, collagen type IV, mdogen) were detected 
lmmunoprecipitation and Electrophoresis 
Surface-racbolabeled MEC were processed for numunopreclpltauon  with 
excess prnuary  anubody  by previously  described  methods  (Cheng  and 
Kramer,  1989)  For SDS-PAGE analysts,  the tmmunopreclpttates  were 
solubfl~ed  m sample buffer,(Laemmh,  1970), with or without fresh 5% 
/3-mercaptocthanol, and heated at 100°C for 5 nun  Racholabeled  polypep- 
Udes recovered In the mununopreclpltates were  ~separated on 7 % gels (non- 
reduced or reduced with 5 %/3-mercaptoethanol) that included prestamed 
molecular weight markers (Sigma Chenucal Co )  The radlolabeled profiles 
were detected  by autoradlography  (Kodak XAR-5 film)  In parallel  nu- 
munopreclpltaUons with control nonunmune anUboches,  neghglble rachoac- 
twlty was recovered m the precipitates (not shown) 
AJ~inity Chromatography 
Sepharose 4B was conjugated to purified lanumn or other proteins as de- 
scribed (Kramer et al, 1989) and ¢qmhbrated with ~ng  buffer (50 mM 
Tns-HCI, pH 7 4, 50 mM octy'l-/3-I)-f,  lucopyranoslde 01 mM phenylmethyl- 
sulfonyl fluoride, and either  1 mM CaC12, MgC12, or MnCI2)  Surface- 
radtolabeled  MEC were lysed in rnumug buffer that contmned 200 mM 
octyl-/3-D-glucopyranoslde  and centrifuged at 700 g for 10 nun, then cen- 
trifuged again at 14,000 g for 15 nun  The resulting sup(~rnatant  was apphed 
to a column (0 5  x  3 cm) of the conjugated Sepharose  The column was 
washed first with ruamng buffer, then with 0 2 M NaCI in runmng buffer, 
then with  10 mM EDTA in runmug buffer without chvalent cataons, and 
finally  1 M  NaCI in runmng  buffer  The capacity  of specific peptldes 
(GRGDSP, GRGESP, or YIGSR-NH2 [Pemnsula Laboratories,  Inc, Bel- 
mont, CA]) to remove bound material from the column was tested by pass- 
mga solntlon of each peptade (1 mg/ral m ruumng buffer) over the column 
FracUons (1 ml) were collected and analyzed by 7 % SDS-PAGE  under re- 
duced and nonreduced condmons, followed by autoradlography 
Immunofluorescence Staining 
We evaluated the ¢hstnbuUon  of  receptors and their colocallzaUon with vtn- 
cuhn by double lmmunofluoresconce stmmng of MEC cultures (Cheng and 
Kramer,  1989) Covershps were coated with lanumn  (50/~g/ml) for 1 h 
MEC were seeded onto the slide chambers m serum-free culture medium 
contanung 01% BSA and incubated for 2 h at 37°C  Cells were then fixed 
m 1% formaldehyde contmmng 5% sucrose, and permeabdlzed by extrac- 
tion with 04% Tnton-X  100 m 50 mM glycl'ne-HC1  in PBS (pH 75) for 
5 nun  After premcubaUon with 1% normal goat serum for 60 nun, the per- 
meablhzed cells were mcuhated for 1 h with various pmrs of the following 
primary anUbod~es rabbit anu~human/3t  receptor, rabbit anU-human/33 
(lib/Ilia), mouse monoclonal anU-vmculm, and mouse monoclonal anu- 
vltronectm receptor (LM142)  After waslung, the samples were incubated 
for 1 h with a mixture of affimty-punfied secondary anuboches (goat anti- 
rabbit IgG-rhodanune, 1 800, and goat anU-mouse IgG-fluorescem, 1 200), 
washed agmn, mounted with Fluoromount-G (Fisher SclenUfic  Co, Pitts- 
burgh, PA), and viewed In a Nlkon nucroscope equipped with eptlununes- 
cent opucs 
Results 
MEC Express both 31 and 33 lntegrins 
We analyzed the mtegrln receptor profile expressed by MEC 
using a series of  monoclonal antibodies specific to individual 
o~ chains of the 3~ famdy and to the o~v chain of the 33 faro- 
The Journal of Cell Biology, Volume 111, 1990  1234 F/gum 1  Immunoprecap~tataon  of mtegnn complexes with specific monoclonal anUbodaes Detergent extracts of surface 12~I-labeled  MEC 
were processed for tmmanopreclp~tat~on  and SDS-PAGE/autorad~ography  as described m Materials and Methods, using the following anta- 
bodies  lanes 1 and 2, anu-B~ (AIIB2), lanes 3 and 4, anta-cq (Ts2t7), lanes 5 and 6, anta-~2 (P1H5), lanes 7and 8, antl-t~s,(PlB5), lanes 
9 and 10, ant~-a5 (B1E5), lanes H  and 12, anta-c~ (GoH3), lanes 13 and 14, antl-t~ (LM142) The ~mmunoprec~p~tates  were processed 
m nonreduced (lanes 1, 3, 5, 7, 9,//, and 13) and reduced 0anes 2, 4, 6, 8, 10, 12, and 14) gels  Pos~taons  of md~wdual mtegnn suburats 
are indicated 
fly  Immunoprec~p~tataon  of surface ~SI-labeled  MEC (F~g 
1) showed that these cells expressed most of the known/~ 
complexes, with c~, a3, and c~ expressed at h~gh levels, ot~ 
and ~1 at moderate levels  Immunoprec~p~tataon wath mono- 
clonaI antibody to the Ctv subumt (LM142, Fig  1, lanes 13 
and 14) or to the complex (LM609, data not shown) of the 
wtronectin receptor recovered s~gmficant  amounts of a~B~ 
w~th the expected electrophoret~c mobfl~tles  of the ot~ and 
/~ subumts  before and after reduclaon  We previously showed 
~I  ~  Co//V 
e.,  A  c~i 
,o 
0 
Figure2  Intubltaon of  cell adhesion to extracellular matrix proteins 
by monoctonal anlabodles  to mtegrm complexes Cells were assayed 
for their attachment m the presence of  various ddutlons of bloclang 
monoclonal anubodles (AIIB2, asc~tes) specific to the/~ subumt, 
as described m Matermls and Methods  k,  103 
that tins complex could be tmmunopreclpltated using anu-l/b/ 
IIIa antlbodaes (Cheng and Kramer,  1989) 
In lmlaal experiments, we exarmned the capacity of block- 
mg antabodaes to interfere with the adhesion of MEC to sub- 
strates coated with purified fibronectm, larmmn, and colla- 
gen types I and IV  Anla-fll monoclonal antibody (AIIB2) 
mh~blted adheslon to all four substrates (Fig  2)  Adhesion 
to larmnm and type IV collagen was sensltave  even to low 
concentrataons of the ant1-/31 antabody, whereas adhesion to 
fibronectan was inhibited by ",,70% at the highest concentra- 
tion  of antabody  As  m  our previous  study  (Cheng  and 
Kramer, 1989) pretreatment of cells with cyclohexlrmde to 
block protein synthesis had no influence on cell adhesion 
(data  not  shown),  thus  the possible  deposltaon of matrix 
components during the short (15 mm) incubation period of 
the adhesion assay appears to be negligible 
We next tested the capacity of monoclonal antlbodaes to 
various mtegnn complexes to mh~b~t adhesion to larmnm 
and  type IV collagen substrates  As  before, anta-/3t  anta- 
body completely blocked adhesion to both llgands  Antabody 
to ad3~ partaally blocked MEC adhesion to lanunm but had 
no  effect on adhesion  to  type IV  collagen  (Fig  3)  The 
antl-a~R  monoclonal antibody (B1E5)  was  without effect 
on these two substrates although it produced slgmficant mhl- 
bmon of cell attachment to fibronectm (not shown)  Unex- 
pectedly, anta-ctv monoclonal antabody (LM142) produced 
moderate mhlbltaon of MEC adhesion to lammm but dad not 
alter  adhesion  to  type IV  collagen  The combmatton  of 
LM142 and GoH3 antabodaes was cumulalave and resulted m 
a  nearly complete mh~b~taon of adhesion to lannmn,  but 
Kramer et al  Et and 83 lntegnn Receptors  for Lammm  1235 80 
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20  sion to extracellular matrix proteins. MEC cells were allowed to 
Figure 4. Effects  of anti-~xj33 monoclonal antibody on MEC adhe- 
"6.  ~_  ~  ",'~  ~  ,¢~  ,,=,  attach to the indicated protein-coated substrates in the presence of 
~  ~  ~  ~  ~  Z  the  different concentrations of monoclonal antibodies to  ¢x,/33 
~+  (LM609, purified IgG), as described in Materials and Methods. 
8  ~  (o) Iauninin; (A) vitronectin; (n) collagen IV. 
Figure 3.  Inhibition of MEC  adhesion to laminin is  partially 
blocked with antibodies to (x6 and c~v. MEC were assayed as de- 
scribed in Fig. 2 in the presence  of  predetermined  dilutions  of  mono- 
clonal antibodies to/~j (AIIB2, ascites), ,',, (LM142, ascites), ~6 
(GoH3, hybridoma supernatant), or as (B1E5, ascites). Note that 
both anti-(x~ and -c~v inhibited attachment to laminin but not colla- 
gen. (m) Ln, (B) Col IV. 
again, no effect on adhesion to type IV  collagen was de- 
tected. 
We next compared the dose-response of antibody against 
the vitronectin receptor complex (LM609) on the attach- 
ment of MEC to type IV collagen, vitronectin, and laminin 
(Fig. 4).  As expected, monoclonai antibody LM609 sub- 
stantially blocked attachment to vitronectin with significant 
inhibition detectable at 0.1/~g/ml. However, on type IV col- 
lagen substrates the antibody had no effect. Finally, on lami- 
nin, the antibody induced a moderate (30%) inhibition that 
was maximal at ,~1 ~g/ml. The inhibitory effect of LM609 
antibody on laminin adhesion was comparable to that pro- 
duced by the LM142 antibody (Fig. 3). 
We have previously shown that RGD-containing peptide 
can inhibit MEC from attaching to immobilized fibronectin 
(Cheng and Kramer,  1989).  We next evaluated the same 
RGD peptide for its ability to influence MEC adhesion to 
type IV collagen, laminin, or vitronectin (Fig. 5). While the 
RGD peptide completely inhibited adhesion to vitronectin, 
it had no effect on adhesion to laminin or type IV collagen, 
even at 1 mg/ml. As expected, the inactive analogue contain- 
ing RGE produced no significant effect on MEC adhesion to 
any of the three substrates (not shown). 
Multiple lntegrin Complexes Bind Laminin 
We  used  ligand  affinity  chromatography  to  probe  the 
specificity and affinity of individual surface receptors for 
laminin. Relative affinity was established by sequential elu- 
tion with (a) 50 mM Tris-HC1 (running buffer), (b) 0.2 M 
NaC1, and finally (c)  10 mM EDTA. We also evaluated the 
influence of divalent cation on ligand-receptor affinity. We 
attempted to recover receptor populations on laminin-Seph- 
arose columns using Ca2*-containing running buffer, but the 
yield of specifically bound integrins was low (not shown). 
However,  in both Mg  2+- and Mn2*-containing  buffers, re- 
producible elution profiles were readily obtained and were 
further analyzed by SDS-PAGE. The complexity of these gel 
patterns was subsequently evaluated by immunoprecipitation 
with a panel of monoclonal antibodies to specific (x subunits 
of the/31 and/53 receptor families. The relative distribution 
of individual integrin complexes eluted in the 0.2 M NaC1 
and EI3q'A fractions is summarized in Table I. 
Chromatography  of  cell  extracts  of  Mg2+-containing 
buffers produced elution profiles that after SDS-PAGE were 
resolved into a  set of radiolabeled bands in the range of 
90-200 kD (Fig. 6). The (x2 subunit was the major binding 
integrin complex present in both the 0.2 M NaCl- and EDTA- 
eluted fractions (Fig. 6 b, lanes 2 and 6). Significant  amounts 
of o~v133 were also detected in both fractions (Fig. 6 b, lanes 
4  and 8).  Trace amounts of o~t~  and ,~  were usually 
present in the 0.2M NaCI fractions. In addition, immuno- 
100, 
i 
u 
o 
o.o  o12  o14  o16  o18  11o 
peptide (mg/ml) 
Figure  5. Effects  ofRGD peptide on MEC adhesion to extracellular 
matrix proteins. MEC cells were allowed  to attach to the indicated 
protein-coated substrates in the presence of GRGDSP peptide, as 
described in Materials and Methods. The peptide inhibited cell 
adhesion to vitronectin but was without effect on attachment to 
laminin or  collagen substrates.  (o)  Col  IV;  (&)  laminin;  (B) 
vitronectin. 
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Laminin-Sepharose Columns 
Mg2  ÷  Mn  2* 
Complex  0.2 M  NaC1  10 raM  EDTA  0.2 M  NaCI  10 mM  EDTA 
C~IBL  -  -  +  +  + 
c~zB1  ++  ++++  +  + 
0~3/~1  .... 
O~5~  1  .... 
ol~  +  -  +  +  +  + 
ol~s  +  +  +  +  +  +  +  + 
MEC were surface labeled with t2sI and the call extract was chromatographed 
on  laminin-Sepharose  in  the  presence  of  the  indicated divalent  cation  as 
described in Figs. 6 and 7.  The relative amounts of individual receptor com- 
plexes in the 0.2 M  NaCI and 10 mM EDTA-cluted fractions is indicated: -, 
trace or undetectable;  +,  minor;  +  to  + +  + +,  low to high amounts. 
precipitation  with  specific monoclonal  antibody  detected 
small amounts of ot3/3~ in the eluted fractions (not shown). 
In Mn2+-containing  buffer, we found a  significantly dif- 
ferent elution profile (Fig. 7). The overall amount of  material 
that bound to the laminin columns was increased from that 
recovered from columns run with Mg2+-containing  buffers. 
The major integrin complex was no longer O~2~  1 but rather 
c~v~s; the av~s complex bound with relatively high affinity; 
c~v~s was only partially recovered with the 0.2 M NaCI wash 
and required EDTA for its complete elution. Moderate amounts 
of o~tB, were also detected but this complex was primarily 
eluted in the 0.2 M NaC1 wash. In contrast, a~B1, present in 
significant levels, was recovered after EDTA elution. As was 
observed  in  column  runs  with  Mg2+-containing  buffers, 
only trace amounts of as~l were eluted (not shown). 
We tested the possibility that o~vfl3 was interacting with 
laminin through an RGD-like determinant by attempting to 
elute  the  bound  receptor  with  either  RGD-  or  RGE- 
containing peptides in Mg2+-containing  running buffer (Fig. 
8). Two identical laminin-Sepharose columns were processed 
in parallel, and after the 0.2 M NaCI wash, were eluted with 
either peptide.  The specific elution of the ~3  subunit was 
monitored after separation by SDS-PAGE.  Both peptides 
produced similar elution profiles that showed the gradual 
elution of tx~B3 and were identical to that obtained in the ab- 
sence of peptide. Complete resistance to elution with RGD 
or RGE peptide was also observed in Mn2+-containing buffer 
Figure 6. Ceil-surface proteins eluted from laminin-Sepharose columns in Mg2+-containing buffer. (a) IzSI-labeled  MEC were solubilized 
in starting buffer containing 1 mM Mg  2+ and the extract (lane 1) was applied to a laminin-Sepharose column, as described in Materials 
and Methods. After washing with starting buffer (lane 2), the column was eluted with 0.2 M NaCI (lanes 3-5) followed by 10 mM EDTA 
(lanes 6-9). Fractions were analyzed by SDS-PAGE under nonreduced conditions. (b) Samples from both the 0.2 M NaCI (lanes 1-4) 
and  10 mM EDTA (lanes 5-8) fractions were immunoprecipitated with monoclonal antibodies to individual ct subunits, including cq 
(lanes 1 and 5), c~2 (lanes 2 and 6), c~6 (lanes 3 and 7), and c~v (lanes 4 and 8); the samples were processed for electropboresis under 
nonreduced conditions. Positions of molecular mass markers arc indicated in kilodaltons. 
Kran~r et al. ~1 and ~3 lntegrin Receptors  for Laminin  1237 Figure 7. Cell-surface proteins eluted from laminin-Sepharose columns in Mn2+-containing buffer. (a) ~25I-labeled  MEC were solubilized 
in starting buffer containing 1 mM of Mn  2+ and the extract (lane 1) was applied to a laminin-Sepharose column as described in Fig. 6. 
After a washing with starting buffer (lane 2), the column was eluted with 0.2 M NaCI (lanes 3-5) followed by 10 mM EDTA (lanes 6--10). 
Fractions were analyzed by SDS-PAGE under nonreduced conditions. (b) Samples from both the 0.2 M NaC1 (lanes 1-4) and 10 mM 
EDTA (lanes 5-8) fractions were immunoprecipitated with monoclonal antibodies to individual c~ subunits, including c~ (lanes I and 5), 
c~2 (lanes 2 and 6), aa (lanes 3 and 7), and ~v (lanes 4 and 8); the samples were processed for electrophoresis under nonreduced condi- 
tions. Positions of molecular mass markers are indicated in kilodaltons. 
(not shown).  These results  suggest that the 0~v/33 complex 
binds to laminin by a mechanism that is not RGD-sensitive 
and also argues against the possibility that there is significant 
contamination of our laminin preparations by nidogen or 
other RGD-containing proteins. We also tested the ability of 
the YIGSR-NH2 peptide to elute the bound receptors, but 
again, no material was specifically released (not shown). 
[3~ and [33 lntegrin Receptors Are Localized in Adhesion 
Plaques on Laminin 
Previously, we described the preferential localization of ~t 
and/33 complexes in MEC to fibronectin- and vitronectin- 
coated surfaces,  respectively (Cheng and  Kramer,  1989). 
We now examined the distribution of integrin complexes in 
MEC spread on laminin substrates,  using immunofluores- 
cent staining with various monoclonal and polyclonal anti- 
bodies. On laminin substrates,/~ complexes were found in 
vinculin-positive focal adhesion plaques (Fig. 9, a  and b). 
These plaques were visible in all divalent cation incubation 
buffers including  Ca2+/Mg  2+,  Mg  2+  alone,  or  Mn  2+ alone. 
Attempts to stain o~6 in focal adhesion plaques were not suc- 
cessful, perhaps due to insufficient numbers of receptors in 
the focal plaques or to sequestering of the epitope after bind- 
ing with laminin. 
Since blocking antibody and ligand-affinity chromatogra- 
phy  experiments  suggested  that  Ctv/~3 could be  mediating 
some of  the adhesive interaction with laminin, we also exam- 
ined the distribution of this  receptor complex on laminin 
substrates.  In CaE+/Mg  2+ buffers, weak staining for/~3 was 
frequently observed at vinculin-adhesion plaques (Fig. 9, c 
and d). However, arrays of focal adhesion plaques contain- 
ing  /33  complexes were  readily detected when  cells  were 
seeded  in  the  presence  of Mg  2÷-  or  especially  in  Mn  2÷- 
containing media (Fig. 9,  e-h).  The degree of/33 receptor 
condensation in focal plaques paralleled the relative affinity 
of ~v/33 for laminin as observed by ligand affinity chroma- 
tography. 
These results are not unique to MEC. In cultured human 
smooth muscle cells isolated from the aorta or in human 
melanoma cell lines (e.g., MeWo, SK-MEL28), c~v/33  appears 
to behave like a laminin receptor as demonstrated by inhibi- 
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tide on the elution of integrin 
receptors from larninin-Seph- 
arose  columns,  t2Sl-labeled 
MEC were solub'dized  in start- 
ing buffer containing 1 mM of 
Mg  2+ and the extract was ap- 
plied to a laminin-Sepharose 
column as described in Fig. 
7. Fractions were eluted with 
0.2 M NaCl (first three lanes), 
followed by buffer containing 
1 mg/ml  of either (a) GRGDSP 
or  (b)  GRGESP 0ast  five 
lanes); samples of each frac- 
tion were processed for elec- 
trophoresis under nonreduced 
conditions. Positions of mo- 
lecular mass markers are indi- 
cated in kilodaltons. 
tion of attachment~to laminin by monoclonal antibody to 
O~vfl3, affinity of~3  to laminin-Sepharose columns, and lo- 
calization of c/vfl~in focal adhesion plaques on laminin sub- 
strates (Clyman, R., and R. H. Kramer, unpublished data). 
Discussion 
The previous  suggestion (Cheng and Kramer,  1989)  that 
MEC express a set of multiple integrin receptor complexes 
was confirmed here by immunoprecipitation with a panel of 
monoclonal antibodies to specific receptors of the fit and t3 
classes.  The major fit heterodimers expressed were c~2fl~, 
c~3fll, and c~sfl~, with lesser amounts of cqfll and c~  (Fig. 
1). The cells also expressed moderate amounts of O~vfl3. A1- 
belda et al. (1989) also reported that cultured human umbili- 
cal vein cells express several of these integrin complexes. 
Given this diverse receptor profile, it is expected that MEC 
can  attach  to  a  variety  of ECM  components,  including 
fibronectin, laminin, vitronectin, collagen types I and IV, 
and denatured collagen (gelatin) (Cheng and Kramer, 1989). 
Laminin is a major adhesive glycoprotein of the vascular 
basement membrane and consists of multiple functional do- 
mains, including an RGD-containing sequence (reviewed in 
Timpl, 1989).  It is not surprising, then, that MEC may use 
several integrin complexes for attachment to this ligand. Our 
results using available blocking antibodies implicate a role 
for both the fit and t3 class of receptors in adhesion to this 
ligand. Since anti-fl~ antibody blocked MEC attachment to 
laminin, this suggests that at least some flrcontaining com- 
plexes are essential during the initial phase of cell attach- 
merit.  Experiments using blocking antibodies (Fig. 3) indi- 
cate that of the fit group of receptor complexes expressed 
by  MEC,  otd~l clearly  contributes  to  cell  adhesion  to 
laminin. 
The ability of anti-ill antibody to completely block MEC 
adhesion to laminin might, at first glance, suggest that other 
receptors  such as B3  complexes are  not important.  How- 
ever, this result can be explained with the following ration- 
ale. The adhesion assay uses a mild shear force to select for 
strongly adherent cells. It is likely that a minimum number 
of receptor-ligand interactions are necessary for initial firm 
attachment, which would be the sum of both the fl~ and t3 
and potentially other types of receptors. In model systems, 
it has been shown that cell binding and spreading on the sub- 
strate are examples of threshold responses.  This threshold 
response reflects not only the density of immobilized ligand 
but also the number of available receptors and the associa- 
tion constant of  the receptors forming the interactions. Thus, 
avfl3 appears to be required for maximal cell attachment to 
laminin; it is not sufficient by itself to provide the necessary 
adhesive threshold. This may be a consequence of low copy 
number per cell or insufficient affinity of ~vfl3 for laminin. 
Ligand-affinity chromatography experiments  supported 
the role of o~  in mediating MEC attachment to laminin. 
This is in agreement with the immunodetection of o~d~ as- 
sociated with capillaries in situ (Sonnenberg et ai.,  1986). 
Lesser amounts of this integrin complex have been detected 
in  the  endothelium  of large  vessels  (Sormenberg  et  al., 
1986),  and cultured human umbilical cord endothelial cells 
have been reported to express only trace amounts of ot~t 
Kramer et al.  fl~ and flj lntegrin Receptors for Laminin  1239 (Languino et al., 1989), suggesting that this integrin may be 
more specific to the microvascular endothelittm,  otd3t has 
been shown to be the major integrin on platelets that medi- 
ates  their  adhesion  to  laminin  (sormenberg  et al.,  1986, 
1988a,b).  Epithelial  cells also express  o~ in  the  form of 
oea3, (Kajiji et al.,  1989);  however,  this complex was not 
detected in the MEC. 
Affinity  chromatography  provided  information  about 
other specific integrin  complexes that might bind laminin 
and promote adhesion to the immobilized ligand. In addition 
to o~d~, integrin  complexes ol~fl~ and o~2fl~ were found to 
bind well to laminin-Sepharose  columns.  Previously, otj3~ 
was shown to bind preferentially to type IV collagen, with 
some affinity for type I collagen as well (Kramer and Marks, 
1989). Various groups have recently shown that, in rodents 
and humans, o~fl~ binds to laminin and collagen (Ignatious 
and Reichardt,  1988;  Turner et al.,  1989; Clyman et al., 
1990; Ramos et al.,  1990), and that monoclonal antibodies 
to at  inhibit certain  cell types from attaching  to laminin 
and collagen (Hall et al., 1990; Turner et al., 1989; Clyman 
et al.,  1990). 
MEC express large amounts of a~B~, a complex that has 
recently been implicated as a laminin receptor. Languino et 
al.  (1989) provided evidence that otz~ in human umbilical 
cord endothelial  cells mediates  adhesion  to laminin.  The 
o~2fl~ complex  is  presumably  also  involved  in  mediating 
MEC  adhesion  to  laminin,  since  this  complex  on  MEC 
bound with moderate affinity to laminin-Sepharose eolurnns. 
The ¢x~ The complex has also been implicated as a recep- 
tor for laminin as well as fibronectin and collagen (Wayner 
and Carter,  1987; Gehlsen et al.,  1988;  1989; Elices et al., 
1990).  While MEC express moderate levels of ot3fl~, only 
trace  amounts  were  recovered  from  laminin-Sepharose 
columns.  This  was  true  regardless  of the divalent  cation 
present. 
However, further studies are needed to define the possible 
role of these fl~ complexes (ot,fl~, ot2flm, and o~3fl~) in MEC 
adhesion to laminin.  Certainly the binding of o~fl~ and ot2B~ 
to laminin-Sepharose colunms and the results of other studies 
would suggest that these receptors may also be important in 
MEC adhesion to laminin.  Although affinity chromatogra- 
phy has been a very useful technique for the identification 
of adhesion  receptors,  it should not be used as the single 
criterion for receptor function or specificity. It is equally im- 
portant to use functional assays, such as blocking antibody 
experiments, to confirm the results of that obtained by affin- 
ity chromatography. 
Several pieces of evidence presented here support the pro- 
posal that the vitronectin receptor can function as a laminin 
receptor,  ot,83 was  shown  to  bind  to  laminin-Sepharose 
columns with moderate affinity.  The association of cecil3 in 
vinculin-positive  focal  adhesion  plaques  on  laminin  sub- 
strates  also implicates  the complex as a  laminin  receptor. 
Some condensation of the receptor was noted in Ca2÷/Mg 2÷- 
containing  buffers,  but  the  associations  were  striking  in 
Mg~*-buffers  and even more so in Mn2÷-huffers.  This de- 
pendency on divalent cation mirrors the receptors binding 
efficiency on laminin-Sepharose columns: M~>Mgv'>Ca 2+. 
The capacity of cells to form focal adhesions is correlated 
with the strength of adhesion to the substrate and apparently 
involves the generation of high affinity interactions between 
the ligand and the receptor that are stabilized by the tyro- 
skeleton (Burridge and Fath,  1989). 
Studies  using  blocking  monoclonal  antibodies  to  o~vB3 
demonstrate its role in the initial cell attachment to laminin. 
LM142 antibody (specific to the c~ subunit) and LM609 anti- 
body (specific to the mature o~-fl complex), significantly in- 
hibited MEC adhesion to laminin. The actual binding site for 
monoclonal antibody LM142 on the ¢, chain has not been 
determined but is believed to be located distal to. the RGD- 
binding  domain  that  interacts  with  vitronectin  and  other 
RGD-containing ligands.  The epitope for the LM609 anti- 
body is present only in the mature ce,fl3 complex and may 
be located near the RGD binding site (Cheresh and Spiro, 
1987; Cheresh and Harper,  1987). LM142 was as or more 
effective than LM609 in blocking attachment to laminln. In 
contrast, LM609 effectively blocked attachment to vitronee- 
tin (Fig. 4), while LM142 produced only minimal inhibition. 
This pattern of blocking on vitronectin has been observed 
previously (Cheresh et al., 1989; Cheresh and Harper, 1987). 
This implies that the site on the ct,  fl3 that is involved in bind- 
ing to vitronectin may differ from those that interact with 
laminin. 
Previous  studies  have  demonstrated  that  cevfl3 binds 
strongly to RGD peptides and such peptides can block the 
interaction of the receptor for its natural ligands including 
vitronectin,  von W~ebrand  factor,  thrombospondin,  and 
fibrinogen (Pytela et al.,  1985;  Cheresh and Spire,  1987; 
Lawler  et  al.,  1988).  The  o~v/53 on  MEC  interact  with 
vitronectin (Fig.  5) and fibrinogen (not shown) through an 
RGD recognition site. We have demonstrated that MEC at- 
tach to laminin by a mechanism that does not appear to be 
RGD-sensitive  and  ccj3~ is  not  eluted  from  the  lami- 
nin-Sepharose  columns with RGD peptides.  The apparent 
recognition site within laminin is as yet unidentified. On the 
other hand,  Grant  et al.  (1989)  recently reported that an 
RGD-containing peptide from the A chain of laminin could 
partially  inhibit  the  adhesion  of umbilical  cord  vein  ew 
dothelial cells to laminin. Again this may reflect differences 
between large and small vessel endothelium. 
The entire  f13 class of integrins  are remarkable  in their 
degree  of  relaxed  ligand  specificity.  Thus,  the  platelet 
llb/l~  (~,B3), can bind a variety of ligands (fibronectin, 
vitronectin,  fibrinogen, yon Willebrand factor, and throm- 
bospondin) (Ginsberg et al., 1988) while a,fl3 can also bind 
several ligands (vitronectin, fibrinogen, yon Willebrand fae- 
Figure 9. Localization of integrin complexes in focal adhesion plaques. MEC were permitted to adhere to laminin-coated coverslips for 
2 h in serum-free culture medium containing Ca2÷/Mg  2÷ (a--d), in culture medium containing only Mg  2÷ (e and f), or in culture medium 
containing only Mn  2÷ (g and h). The samples were then fixed, perrneabflized, and stained for double immunofluoreseence as described 
in Materials and Methods: rabbit polyclonal antibody to the fit subunit (a) or the B3 subunit (c, e, and g), and mouse monoclonal antibody 
to vineulin (b, d, f, and h). The fl~- (a) and fl3-containing complexes (c, e, and g) are concentrated in focal adhesion plaques (arrows), 
usually at the marginal edge of the cell. Bar, 10/~m. 
Kran~r et al. fit and flj Integrin Receptors f~r laminin  1241 tor,  thrombospondm,  and  now  apparently,  larmmn)  The 
o~nbB3 complex also sets a precedent for a dual speclficxty 
system  in  whmh  both  RGD  and  non-RGD  sequences  on 
fibrmogen  (GGAKQGDV)  can  interact  w~th the  adhesion 
receptor (Cheresh et al, 1989b, Tanqul et al., 1989)  In addi- 
tion, a recently xdentlfied complex related to the vltronectm 
receptor, the o~3~, can bind fibronectm and wtronectm, but 
not  fibnnogen  or yon  Wfllebrand  factor (Cheresh  et  al, 
1989b)  Usually such promiscmty revolves the presence of 
RGD-11ke recognmon  sequences  m  most  of the  effective 
hgands 
With  the 3~ group of mtegnns,  many  appear  to display 
multaple hgand interactions that do not depend on RGD-hke 
recogmtlon s~tes  For example, tx~3~ and o~:3~ can brad to 
collagens as well as lam~mn (Ignataous and Relchardt,  1988, 
Kramer and Marks,  1989, Langulno et al,  1989), o~31 can 
bind  to  collagen  lanunm,  and  fibttmectan  (Wayner  and 
Carter,  1987),  and, o~4B~ binds  to both  cell-celLadhes~on 
s~tes (Holzman  et al,  1989)  and tq, the  CS-1  domain  of 
fibronectan  (Wayner  et  al,  1989).  This  suggests  that  the 
receptor must be binding to different deterrmnants on each 
hgand, perhaps through  multiple and distinct binding sites 
on the lntegrm complex 
There ~s evidence that variant forms ofa Vltronectan recep- 
tor exist  For example, Freed et al  (1989) recently reported 
that  osteosarcoma  cells  express  a  umque  complex  (CtvB~) 
that  &ffers  from the  classical  o~J~  However,  the  hgand 
specificity of th~s new complex and ~ts relataonsh~p to o~3~ 
remains to be estabhshed  Various  lymphoid cells that ex- 
press  one  or  more  novel  av/3rhke  lntegrms  have  been 
~dent~fied with umque llgand specificity (reviewed In Hem- 
ler, 1990)  Finally,  ~t appears that ot~ can assocmte w~th the 
~1 subumt on certain cell types (Bodary and McLean,  1990) 
It IS possible that the ot~B3 expressed on MEC ~s a variant 
form of the complex that differs functionally from the classi- 
cal ~x~3~ complex  However, ~mmunopreclpltataon  with ei- 
ther  anta-3~-  or  anta-~Xv-SpeclfiC antabodles  appears  to 
confirm that  MEC  express  a  homogeneous  population  of 
c~J~ complexes whose subumts exbablt the correct mobility 
before and after reducUon of disulfide bonding  In sequential 
lmmunoprec~pltatton  studms,  antl-/~s  anUbody  could  lm- 
munoprec~p~tate all the C~v chmn of the receptor complex, 
and wce versa (not shown)  However, we cannot exclude the 
poss~blhty  that small amounts of Otv3~ or o~B~ are present 
It ~s possible that MEC may d~rectly modulate either the 
receptor-hgand  affimty  or  the  hgand  specificity  of ¢xJ~3 
For example,  there  is evidence that ~xe/~t acts as a lanunln 
receptor in certain cell types, yet m other cells it funcuons 
only as a collagen receptor (Karchhofer et al, 1990)  Indeed, 
we have noted some variability  in the adhesion of MEC to 
matrix hgands that may reflect alterations m receptor expres- 
sion and/or functaon  Receptor function may be altered at the 
molecular level or by changes m the nucroenwronment at the 
cell surface  It has been recently reported (van Kuppevelt  et 
al , 1989) that the B~ subumt can be alternatively  sphced at 
~ts COOH-terrmnal  end, thereby providing a mechamsm to 
regulate  mteractaon  with  the  cytoskeleton  Addmonally, 
secretion of growth factors  such  as  transforrmng  growth 
factor-fl could modulate receptor levels (Hemo and Massague, 
1989)  The mterestang poss~bfllty that mtegrms may express 
varmbd~ty m  their affimty/speclfiC~ty deserves further study 
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